KLRS - Latest News
Kalaris Therapeutics Inc (KLRS), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $48.7M. Beta to the broader market is 0.21.
The article list below shows the most recent KLRS headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent KLRS Headlines
Kalaris Therapeutics Inc. (NASDAQ:KLRS) Stock Has Average Price Target of $18.75
defenseworld.net - Sep 28, 2026
Kalaris Therapeutics Inc. (NASDAQ: KLRS - Get Free Report) has been given an average recommendation of "Moderate Buy" by the seven brokerages that ar
Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare Conference
globenewswire.com - Aug 31, 2026
BERKELEY HEIGHTS, N. J.
Kalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com - Aug 11, 2026
Patient dosing is ongoing in the Phase 1b/2 study of TH103; preliminary data anticipated in 1H 2027 Potential Phase 3 clinical trials remain on track
Kalaris Therapeutics (NASDAQ:KLRS) Shares Up 15.4% – Here’s What Happened
defenseworld.net - Aug 4, 2026
Kalaris Therapeutics Inc. (NASDAQ: KLRS - Get Free Report)'s stock price rose 15.
KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders
globenewswire.com - Aug 3, 2026
Abbott Cooper PLLC is investigating fiduciary duty claims for Kalaris Therapeutics (formerly AlloVir) holders who owned shares before November 7, 2024
How News Affects KLRS Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track KLRS's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked KLRS news questions
- What is the latest KLRS news headline?
- The most recent KLRS headline (Sep 28, 2026) is "Kalaris Therapeutics Inc. (NASDAQ:KLRS) Stock Has Average Price Target of $18.75". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the KLRS news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What KLRS news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual KLRS options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.